COMPANY PROFILE
| Price and Volume | |
|---|---|
| Recent Price | 23.29 |
| 52 Week High | 24.29 |
| 52 Week Low | 6.14 |
| Avg. Daily Vol. (Mil) | 1.01 |
| Beta (3 year) | 0.63 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,149.23 |
| Shares Out (Mil) | 49.34 |
| Float (Mil) | 46.86 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.60 |
| Current Ratio | 2.00 |
| LT Debt/ Equity | 0.27 |
| Total Debt / Equity | 0.27 |
| Valuation Ratios | |
| Price Earnings | N.A. |
| Price/Sales | 5.15 |
| Price/Book | 4.84 |
| Price/Cash Flow | -36.10 |
| Per Share Data | |
| Earnings | -0.98 |
| Sales | 4.52 |
| Book Value | 4.81 |
| Cash Flow | -0.64 |
| Business Summary | |
|---|---|
| A specialty pharmaceutical company, which is dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract. | |
| General Information | |
| 1700 Perimeter Park Drive
Morrisville, NC 27560 |
|
| www.salixpharm.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 280 | |
| CEO: Carolyn J. Logan | |
| Short Interest | |
| Current Month (Mil) | 3.65 |
| Previous Month (Mil) | 3.30 |
| Short Interest Ratio (Days) | 5.70 |
| Management Effectiveness | |
| Return on Equity | N.A. |
| Return on Assets | -12.10 |
| Return on Investments | -15.00 |
| Profitability | |
| Gross Margin | 80.10 |
| EBIT Margin | -19.60 |
| Profit Margin | -21.10 |